These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 20032807)

  • 1. Kawasaki disease patients with redness or crust formation at the Bacille Calmette-Guérin inoculation site.
    Uehara R; Igarashi H; Yashiro M; Nakamura Y; Yanagawa H
    Pediatr Infect Dis J; 2010 May; 29(5):430-3. PubMed ID: 20032807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reaction at the bacillus Calmette--Guérin inoculation site in patients with Kawasaki disease.
    Lai CC; Lee PC; Wang CC; Hwang BT; Meng CC; Tsai MC
    Pediatr Neonatol; 2013 Feb; 54(1):43-8. PubMed ID: 23445742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human herpes virus type 6 can cause skin lesions at the BCG inoculation site similar to Kawasaki Disease.
    Kakisaka Y; Ohara T; Katayama S; Suzuki T; Sasai S; Hino-Fukuyo N; Kure S
    Tohoku J Exp Med; 2012 Dec; 228(4):351-3. PubMed ID: 23138414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erythema and induration of the Bacillus Calmette-Guérin site for diagnosing Kawasaki disease.
    Loh ACE; Kua PHJ; Tan ZL
    Singapore Med J; 2019 Feb; 60(2):89-93. PubMed ID: 30009317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reaction of the BCG Scar in the Acute Phase of Kawasaki Disease in Mexican Children.
    Garrido-García LM; Castillo-Moguel A; Vázquez-Rivera M; Cravioto P; Fernando G
    Pediatr Infect Dis J; 2017 Oct; 36(10):e237-e241. PubMed ID: 28498302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of factors associated with development of Bacille Calmette-Guérin inoculation site change in patients with Kawasaki disease.
    Araki T; Kodera A; Kitada K; Fujiwara M; Muraoka M; Abe Y; Ikeda M; Tsukahara H
    J Int Med Res; 2018 Apr; 46(4):1640-1648. PubMed ID: 29512398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two infants with tuberculid associated with Kawasaki disease.
    Yamada H; Ohta H; Hasegawa S; Azuma Y; Hasegawa M; Kadoya R; Ohbuchi N; Ohnishi Y; Okada S; Hoshide M; Ohga S
    Hum Vaccin Immunother; 2016 Nov; 12(11):2772-2776. PubMed ID: 27435523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Local skin redness and irritation five months after Bacillus Calmette Guerin (BCG) vaccination as a sign for Kawasaki's disease].
    Edelman K; Korvenranta H
    Duodecim; 1996; 112(8):698-700. PubMed ID: 10592640
    [No Abstract]   [Full Text] [Related]  

  • 9. BCG and Kawasaki disease in Mexico and Japan.
    Gamez-Gonzalez LB; Hamada H; Llamas-Guillen BA; Ruiz-Fernandez M; Yamazaki-Nakashimada M
    Hum Vaccin Immunother; 2017 May; 13(5):1091-1093. PubMed ID: 28281896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bacille Calmette-Guérin vaccine-induced disease in HIV-infected and HIV-uninfected children.
    Hesseling AC; Rabie H; Marais BJ; Manders M; Lips M; Schaaf HS; Gie RP; Cotton MF; van Helden PD; Warren RM; Beyers N
    Clin Infect Dis; 2006 Feb; 42(4):548-58. PubMed ID: 16421800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bacille Calmette-Guérin inoculation site changes and cardiac complications in patients with Kawasaki disease.
    Takikawa H; Ae R; Matsubara Y; Matsubara D; Makino N; Kosami K; Kuwabara M; Sasahara T; Nakamura Y
    Arch Dis Child; 2021 Jul; 106(7):669-673. PubMed ID: 33303488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunity status in children with Bacille Calmette-Guerin adenitis. A prospective study in Tehran, Iran.
    Samileh N; Ahmad S; Farzaneh A; Shahnaz R; Lida F; Mohammad N
    Saudi Med J; 2006 Nov; 27(11):1719-24. PubMed ID: 17106549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Diagnosis of incomplete Kawasaki disease].
    Tsuchiya K; Imada Y; Aso S; Sonobe T
    Nihon Rinsho; 2008 Feb; 66(2):321-5. PubMed ID: 18260331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kawasaki disease in children with Bacillus Calmette-Guérin scar reactivity: Focus on coronary outcomes.
    Yang MC; Wu KL; Huang CN; Liu YC; Chien YH; Fu CM; Lim HK; Chin CY; Wu JR; Liu HM; Sun LC; Lee CY; Su YH; Wang YF; Lin MT
    J Formos Med Assoc; 2023 Oct; 122(10):1001-1007. PubMed ID: 37142476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disseminated bacille Calmette-Guérin in Iranian children with severe combined immunodeficiency.
    Sadeghi-Shabestari M; Rezaei N
    Int J Infect Dis; 2009 Nov; 13(6):e420-3. PubMed ID: 19403320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors associated with latent tuberculosis infection in Mexican American children.
    Young J; O'Connor ME
    Pediatrics; 2005 Jun; 115(6):e647-53. PubMed ID: 15930191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An ulcerated lesion at the BCG vaccination site during the course of Kawasaki disease.
    Kuniyuki S; Asada M
    J Am Acad Dermatol; 1997 Aug; 37(2 Pt 2):303-4. PubMed ID: 9270532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bacillus Calmette-Guérin reactivation as a sign of incomplete Kawasaki disease.
    Novais C; Fortunato F; Bicho A; Preto L
    BMJ Case Rep; 2016 Mar; 2016():. PubMed ID: 27033285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What does tuberculin reactivity after bacille Calmette-Guérin vaccination tell us?
    Menzies D
    Clin Infect Dis; 2000 Sep; 31 Suppl 3():S71-4. PubMed ID: 11010826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measles infection causing Bacillus Calmette-Guérin reactivation: a case report.
    Muthuvelu S; Lim KS; Huang LY; Chin ST; Mohan A
    BMC Pediatr; 2019 Jul; 19(1):251. PubMed ID: 31340782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.